Valuation: Novartis AG

Market Cap 278B 244B 225B 207B 391B 26,822B 398B 2,690B 1,055B 13,112B 1,044B 1,022B 45,194B P/E 2026 *
21.2x
P/E 2027 * 18x
Enterprise Value 310B 272B 251B 231B 437B 29,907B 443B 3,000B 1,176B 14,621B 1,165B 1,139B 50,393B EV / Sales 2026 *
5.45x
EV / Sales 2027 * 5.08x
Free-Float
91.66%
Yield 2026 *
2.93%
Yield 2027 * 3.02%
1 day-0.75%
1 week-0.98%
Current month-2.55%
1 month+3.88%
3 months+4.89%
6 months+7.23%
Current year+12.66%
1 week 121.48
Extreme 121.48
125.66
1 month 118.54
Extreme 118.54
129.4
Current year 107.88
Extreme 107.88
130.54
1 year 91.36
Extreme 91.36
130.54
3 years 81.55
Extreme 81.55
130.54
5 years 73.14
Extreme 73.14
130.54
10 years 68.07
Extreme 68.07
130.54
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Chief Tech/Sci/R&D Officer 64 2022-05-15
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-0.98% - - 284B
-2.73%-3.51%+48.62%+152.87% 1,051B
-1.67%-3.18%+52.00%+56.75% 609B
-0.44%+2.14%+33.88%+84.04% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.70%-3.54%+20.26%+17.88% 263B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+0.21%+23.55%+56.94% 198B
-0.80%+2.60%+23.09%+68.71% 167B
-1.20%+2.40%+1.14%-32.08% 143B
Average -0.19%+0.88%+23.33%+43.23% 381.56B
Weighted average by Cap. +0.34%+0.13%+33.99%+74.17%

Financials

2026 *2027 *
Net sales 56.91B 49.86B 46.1B 42.39B 80.1B 5,488B 81.36B 550B 216B 2,683B 214B 209B 9,247B 60.31B 52.85B 48.86B 44.92B 84.89B 5,816B 86.23B 583B 229B 2,843B 226B 222B 9,800B
Net income 14.08B 12.34B 11.41B 10.49B 19.82B 1,358B 20.13B 136B 53.39B 664B 52.86B 51.71B 2,288B 15.64B 13.71B 12.67B 11.65B 22.02B 1,509B 22.37B 151B 59.32B 737B 58.74B 57.46B 2,542B
Net Debt 32B 28.04B 25.92B 23.83B 45.04B 3,086B 45.75B 310B 121B 1,508B 120B 118B 5,199B 28.48B 24.95B 23.07B 21.21B 40.09B 2,746B 40.72B 275B 108B 1,343B 107B 105B 4,628B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26-07-20 CHF 123.66 -0.75% 130,000
26-07-17 CHF 124.60 +1.57% 130,000
26-07-16 CHF 122.68 +0.36% 130,000
26-07-15 CHF 122.24 -0.36% 130,000
26-07-14 CHF 122.68 -1.41% 130,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
151.94USD
Average target price
152.73USD
Spread / Average Target
+0.52%

Quarterly revenue - Rate of surprise